乔淦，博士后
2009.09-2013.06，河南城建学院/学士/生物技术专业
2013.09-2016.06，青岛科技大学/硕士/轻工技术与工程专业
2016.09-2019.06，首都医科大学/博士/药理学专业
2019.07-2025.10，西南医科大学药理学系/讲师
2025.11-至今，江南大学轻工技术与工程博士后流动站，合作导师：刘立明
主持项目:
四川省青年科学基金（2023NSFSC1675）
代表性论文成果:
[1] Li, Zhendong, Gan Qiao, Xianghe Wang, Ming Wang, Jinyu Cheng, Guipeng Hu, Xiaomin Li, et.al, Li ming, Liu*. De novo designed protein guiding targeted protein degradation. Nature Communications, 2025, 16: 6598.
[2] Qiao, Gan, Roudian Lin, Yongxiang Lu, Jianping Wu, Chunyang Ren, Minghua Liu, and Chunxiang Zhang*. Empagliflozin inhibits cardiac hypertrophy via a mechanism involving integrin signalling. British Journal of Pharmacology. 2026, accepted.
[3] Qiao, Gan, Yongxiang Lu, Jianping Wu, Chunyang Ren, Minghua Liu, Sicheng Liang, and Chunxiang Zhang*. 2025. Empagliflozin preserves cardiomyocyte structural homeostasis via the stabilization of the integrin α5–desmocollin-2 adhesion axis in sepsis-induced cardiomyopathy. Cells, 2025, 14: 1452.
[4] Qiao, Gan, Jinshan Xing, Xin Luo, Chunxiang Zhang, and Jingyan Yi*. 2022. Integrated bioinformatics analysis and screening of hub genes in polycystic ovary syndrome. Endocrine, 2022, 78: 615–627.
[5] Yi, Jingyan, Xin Luo, Jinshan Xing, Aharon Gedanken, Xiukun Lin, Chunxiang Zhang, and Gan Qiao*. 2023. Micelle encapsulation zinc-doped copper oxide nanocomposites reverse Olaparib resistance in ovarian cancer by disrupting homologous recombination repair. Bioengineering & Translational Medicine, 2023; 8: e10507.
论文成果:
Ⅰ. 一种靶向钠-葡萄糖协同转运蛋白2的微小结合蛋白及其构建方法、应用. 授权专利号：ZL 202410328004.6
Ⅱ. Small RNA-based drug, preparation and use thereof in prophylaxis and/or treatment of cardiomyopathy. 美国专利号：US 12,473,551 B2
Ⅲ. 一种小分子RNA候选药物序列优化及其在糖尿病心肌病治疗中的应用. 授权专利号：ZL 202311589842.0
